PF-06649751 low dose (1 mg QD) for parkinson disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trials ended early. Its trials were stopped early. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Feb 2016: Trial registered, NCT02687542
  2. 3 Mar 2016: Trial started, NCT02687542
  3. 10 Nov 2017: Trial terminated, NCT02687542
  4. 24 Dec 2018: Trial results posted, NCT02687542

The trials

NCT02687542: Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations

State
Stopped early
Phase
Phase 2
People
108 taking part
Started
3 Mar 2016
Primary completion
10 Nov 2017
Arms
PF-06649751 low dose (1 mg QD)
Results
Posted on the registry
  1. 22 Feb 2016: Trial registered
  2. 3 Mar 2016: Trial started
  3. 10 Nov 2017: Trial terminated
  4. 24 Dec 2018: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Trials ended early

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.